| Category: Index Fund |
| Launch Date: 14-12-2022 |
| Asset Class: |
| Benchmark: NIFTY Pharma TRI |
| Expense Ratio: 0.98% As on (31-05-2025) |
| Status: Open Ended Schemes for subscription |
| Minimum Investment: 1000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 8.43 Cr As on (30-05-2025) |
| Turn over: 180 |
Scheme Performance (%) Data as on - 26-06-2025
| 1-Year Ret (%) | 3-Yrs Ret (%) | 5-Yrs Ret (%) | 10-Yrs Ret (%) | Since Launch Ret (%) | |
|---|---|---|---|---|---|
| ICICI Prudential Nifty Pharma Index Fund - Growth | 11.13 | - | - | - | 22.29 |
| Nifty Pharma TRI | 12.3 | 22.27 | 17.37 | 6.81 | 14.41 |
| Index Fund | 6.22 | 18.19 | 21.02 | 12.29 | 10.41 |
Yearly Performance (%)
Fund Managers
Nishit Patel
Investment Objective
The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
Growth of 10000 In SIP (Fund vs Benchmark)
Growth of 10000 In LUMPSUM (Fund vs Benchmark)
Rolling Returns
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Riskometer
| Key Statistics | Volatility | Sharpe Ratio | Alpha | Beta | Yield to Maturity | Average Maturity |
|---|---|---|---|---|---|---|
| ICICI Prudential Nifty Pharma Index Fund - Growth | ||||||
| Index Fund | - | - | - | - | - | - |
Asset Allocation (%)
Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund, or designing a portfolio that suits your needs.
Mf Online Inc (with ARN code 160300) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
